Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Systemic recovery and therapeutic effects of transplanted allogenic and xenogenic mesenchymal stromal cells in a rat blunt chest trauma model.

Amann EM, Rojewski MT, Rodi S, Fürst D, Fiedler J, Palmer A, Braumüller S, Huber-Lang M, Schrezenmeier H, Brenner RE.

Cytotherapy. 2017 Dec 6. pii: S1465-3249(17)30720-X. doi: 10.1016/j.jcyt.2017.11.005. [Epub ahead of print]

2.

International Forum on GMP-grade human platelet lysate for cell propagation: summary.

Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, Lόpez-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K.

Vox Sang. 2017 Oct 26. doi: 10.1111/vox.12593. [Epub ahead of print] No abstract available.

PMID:
29076169
3.

International Forum on GMP-grade human platelet lysate for cell propagation.

Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Öller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schäfer R, Bakchoul T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanashi M, López-Villar O, Burnouf T, Reems JA, Pierce J, Preslar AM, Schallmoser K.

Vox Sang. 2017 Oct 25. doi: 10.1111/vox.12594. [Epub ahead of print] No abstract available.

PMID:
29071726
4.

A subpopulation of stromal cells controls cancer cell homing to the bone marrow.

Rossnagl S, Ghura H, Groth C, Altrock E, Jakob F, Schott S, Wimberger P, Link T, Kuhlmann JD, Stenzl A, Hennenlotter J, Todenhöfer T, Rojewski M, Bieback K, Nakchbandi IA.

Cancer Res. 2017 Oct 24. pii: canres.3507.2016. doi: 10.1158/0008-5472.CAN-16-3507. [Epub ahead of print]

PMID:
29066511
5.

Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach.

Granchi D, Gómez-Barrena E, Rojewski M, Rosset P, Layrolle P, Spazzoli B, Donati DM, Ciapetti G.

Stem Cells Int. 2017;2017:3674045. doi: 10.1155/2017/3674045. Epub 2017 Jun 20.

6.

GMP-Compliant Expansion of Clinical-Grade Human Mesenchymal Stromal/Stem Cells Using a Closed Hollow Fiber Bioreactor.

Barckhausen C, Rice B, Baila S, Sensebé L, Schrezenmeier H, Nold P, Hackstein H, Rojewski MT.

Methods Mol Biol. 2016;1416:389-412. doi: 10.1007/978-1-4939-3584-0_23.

PMID:
27236685
7.

Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.

Schneider V, Zhang L, Rojewski M, Fekete N, Schrezenmeier H, Erle A, Bullinger L, Hofmann S, Götz M, Döhner K, Ihme S, Döhner H, Buske C, Feuring-Buske M, Greiner J.

Int J Cancer. 2015 Nov 1;137(9):2083-92. doi: 10.1002/ijc.29583. Epub 2015 May 13.

8.

Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate.

Brennan MÁ, Renaud A, Amiaud J, Rojewski MT, Schrezenmeier H, Heymann D, Trichet V, Layrolle P.

Stem Cell Res Ther. 2014 Oct 13;5(5):114. doi: 10.1186/scrt504.

9.

Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells.

Fekete N, Erle A, Amann EM, Fürst D, Rojewski MT, Langonné A, Sensebé L, Schrezenmeier H, Schmidtke-Schrezenmeier G.

Tissue Eng Part C Methods. 2015 Feb;21(2):112-22. doi: 10.1089/ten.TEC.2013.0766. Epub 2014 Jul 22.

10.

Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.

Wuchter P, Bieback K, Schrezenmeier H, Bornhäuser M, Müller LP, Bönig H, Wagner W, Meisel R, Pavel P, Tonn T, Lang P, Müller I, Renner M, Malcherek G, Saffrich R, Buss EC, Horn P, Rojewski M, Schmitt A, Ho AD, Sanzenbacher R, Schmitt M.

Cytotherapy. 2015 Feb;17(2):128-39. doi: 10.1016/j.jcyt.2014.04.002. Epub 2014 May 20. Review.

PMID:
24856898
11.

S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes.

Eisenbacher JL, Schrezenmeier H, Jahrsdörfer B, Kaltenmeier C, Rojewski MT, Yildiz T, Beyer T, Erle A, Wiegmann DS, Grassl S, Hang R, Körper S, Wiesneth M, Lotze MT, Lotfi R.

J Immunol. 2014 Jun 15;192(12):6102-10. doi: 10.4049/jimmunol.1303144. Epub 2014 May 2.

12.

Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy.

Schneider V, Zhang L, Bullinger L, Rojewski M, Hofmann S, Wiesneth M, Schrezenmeier H, Götz M, Botzenhardt U, Barth TF, Döhner K, Döhner H, Greiner J.

Leukemia. 2014 Aug;28(8):1759-62. doi: 10.1038/leu.2014.116. Epub 2014 Mar 28. No abstract available.

PMID:
24675106
13.

Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI.

Vernikouskaya I, Fekete N, Bannwarth M, Erle A, Rojewski M, Landfester K, Schmidtke-Schrezenmeier G, Schrezenmeier H, Rasche V.

Contrast Media Mol Imaging. 2014 Mar-Apr;9(2):109-21. doi: 10.1002/cmmi.1544.

PMID:
24523056
14.

TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds.

Qi Y, Jiang D, Sindrilaru A, Stegemann A, Schatz S, Treiber N, Rojewski M, Schrezenmeier H, Vander Beken S, Wlaschek M, Böhm M, Seitz A, Scholz N, Dürselen L, Brinckmann J, Ignatius A, Scharffetter-Kochanek K.

J Invest Dermatol. 2014 Feb;134(2):526-537. doi: 10.1038/jid.2013.328. Epub 2013 Aug 6.

15.

Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.

Veronesi E, Murgia A, Caselli A, Grisendi G, Piccinno MS, Rasini V, Giordano R, Montemurro T, Bourin P, Sensebé L, Rojewski MT, Schrezenmeier H, Layrolle P, Ginebra MP, Panaitescu CB, Gómez-Barrena E, Catani F, Paolucci P, Burns JS, Dominici M.

Tissue Eng Part C Methods. 2014 Mar;20(3):239-51. doi: 10.1089/ten.TEC.2013.0250. Epub 2013 Aug 20.

16.

Essential components for ex vivo proliferation of mesenchymal stromal cells.

Fekete N, Rojewski MT, Lotfi R, Schrezenmeier H.

Tissue Eng Part C Methods. 2014 Feb;20(2):129-39. doi: 10.1089/ten.TEC.2013.0061. Epub 2013 Jul 5.

PMID:
23713576
17.

T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/βTREC ratio and thymic naive T cells.

Ringhoffer S, Rojewski M, Döhner H, Bunjes D, Ringhoffer M.

Haematologica. 2013 Oct;98(10):1600-8. doi: 10.3324/haematol.2012.072264. Epub 2013 Apr 12.

18.

Absence of CC chemokine receptors 2a and 2b from human adipose lineage cells.

Koenig C, Fischer-Posovszky P, Rojewski MT, Tews D, Schrezenmeier H, Wabitsch M, Gierschik P, Moepps B.

Mol Cell Endocrinol. 2013 Apr 30;369(1-2):72-85. doi: 10.1016/j.mce.2013.01.008. Epub 2013 Jan 29.

PMID:
23376609
19.

GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system.

Rojewski MT, Fekete N, Baila S, Nguyen K, Fürst D, Antwiler D, Dausend J, Kreja L, Ignatius A, Sensebé L, Schrezenmeier H.

Cell Transplant. 2013;22(11):1981-2000. doi: 10.3727/096368912X657990. Epub 2012 Oct 25.

PMID:
23107560
20.

GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.

Fekete N, Rojewski MT, Fürst D, Kreja L, Ignatius A, Dausend J, Schrezenmeier H.

PLoS One. 2012;7(8):e43255. doi: 10.1371/journal.pone.0043255. Epub 2012 Aug 14.

Supplemental Content

Loading ...
Support Center